ACTU (Actuate Therapeutics) General and Admin. Expense: $12.20 Mil (TTM As of Mar. 2026)


ACTU Actuate Therapeutics Inc ACTU
14 GF Score
Price $1.82
View Full Analysis

What is Actuate Therapeutics General and Admin. Expense?

Actuate Therapeutics ACTU -14.29% 14 General and Admin. Expense is $12.20 Mil as of Mar. 2026. GuruFocus rates ACTU with a GF Score™ of 14/100.

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. Actuate Therapeutics's General and Admin. Expense for the three months ended in Mar. 2026 was $3.14 Mil. Its General and Admin. Expense for the trailing twelve months (TTM) ended in Mar. 2026 was $12.20 Mil.

Actuate Therapeutics General and Admin. Expense Related Terms

Actuate Therapeutics General and Admin. Expense Historical Data

* Premium members only.

The historical data trend for Actuate Therapeutics's General and Admin. Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Actuate Therapeutics General and Admin. Expense Chart

Actuate Therapeutics Annual Data
Trend Dec22 Dec23 Dec24 Dec25
General and Admin. Expense
3.82 3.27 6.48 12.20

Actuate Therapeutics Quarterly Data
Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
General and Admin. Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.15 3.20 3.29 2.56 3.14
ACTU
14GF Score
Actuate Therapeutics Inc ACTU
General and Admin. Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Actuate Therapeutics General and Admin. Expense Calculation

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company.

General and Admin. Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $12.20 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a General and Admin. Expense of $12.20 Mil mean?
Actuate Therapeutics (ACTU) has a General and Admin. Expense of $12.20 Mil as of Mar. 2026. General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. View historical data on Actuate Therapeutics and its competitors.
Is Actuate Therapeutics' General and Admin. Expense too high?
Actuate Therapeutics' current General and Admin. Expense is $12.20 Mil. Overall, Actuate Therapeutics has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does Actuate Therapeutics' General and Admin. Expense compare to AURX and ESLA?
Actuate Therapeutics' General and Admin. Expense of $12.20 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good General and Admin. Expense for a Biotechnology company?
A good General and Admin. Expense depends on the Biotechnology industry context. However, General and Admin. Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high General and Admin. Expense mean?
A high General and Admin. Expense can signal that a stock is expensive relative to its fundamentals. General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. View historical data on Actuate Therapeutics and its competitors. Actuate Therapeutics's current General and Admin. Expense is $12.20 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Actuate Therapeutics stock overvalued right now?
Actuate Therapeutics (ACTU) has a current General and Admin. Expense of $12.20 Mil. The current General and Admin. Expense is $12.20 Mil. Actuate Therapeutics' overall GF Score™ is 14/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is General and Admin. Expense calculated?
General and Admin. Expense is calculated from a company's financial statements. For Actuate Therapeutics (ACTU), the current General and Admin. Expense is $12.20 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Actuate Therapeutics Business Description

Address 1751 River Run, Suite 400, Fort Worth, TX, USA, 76107
Actuate Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing therapies for the treatment of high impact, difficult to treat cancers through the inhibition of glycogen synthase kinase-3 (GSK-3). It is developing elraglusib (formerly 9-ING-41), a small molecule that is designed to enter cancer cells and block the function of the enzyme GSK-3B, a master regulator of complex biological signaling cascades, including those mediated by oncogenes, that lead to tumor cell survival, growth, migration, and invasion.
14GF Score

Get the complete analysis for ACTU

General and Admin. Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.82
Price